Peter Beitsch, MD, provides comprehensive breast cancer care at his practice at Dallas Surgical Group, including breast cancer surgery, identifying and treating women at high risk for breast cancer, and genetic testing. He also specializes in the diagnosis and treatment of melanoma and rare or complex skin cancers.
Dr. Beitsch graduated third in his class at the University of Texas (UT) Southwestern Medical School in Dallas. He completed his General Surgery Residency at UT Southwestern during which he completed a National Cancer Institute fellowship at MD Anderson Cancer Center in Houston. He completed his Surgical Oncology Fellowship at the John Wayne Cancer Institute in Santa Monica, California. He trained with the father of sentinel lymph node biopsy, Dr. Donald Morton, and brought this innovative technique back to Dallas. Dr. Beitsch has received ASBS-certification in breast ultrasound.
Dr. Beitsch is a fellow of the American College of Surgeons, where he’s active in breast cancer research and has placed hundreds of women into cutting-edge studies in partial breast irradiation, genomics, and cancer genetics. His other main research focus is in melanoma, serving as an investigator in the Sunbelt Melanoma Trial and the Multicenter Selective Lymphadenectomy Trial II. He is currently participating in the MAVIS melanoma vaccine study, neo-adjuvant breast cancer registries and the iGAP Registry (a continuation of his Universal Breast Cancer Genetic Testing Registry which recommended changing testing guidelines to include ALL women with breast cancer).